Literature DB >> 23276592

Shape of vaginal suppositories affects willingness-to-try and preference.

Bangde Li1, Toral Zaveri, Gregory R Ziegler, John E Hayes.   

Abstract

HIV and other sexually transmitted infections (STIs) are a global threat to public health that may be countered, in part, by microbicides. A successful microbicide must be both biologically efficacious and highly acceptable to users. Sensory attributes have a direct influence on product acceptability. We created a series of vaginal suppositories appropriate for use as microbicides to investigate the influence of shape on women's willingness-to-try. The influence of perceived size and firmness on acceptability was also assessed. Sexually-active women (n=99) were invited to participate in an evaluation of vaginal suppositories in 5 different shapes including: Bullet, Long Oval, Round Oval, Teardrop and Tampon. The volume (3mL) and formulation for these five prototypes were identical. After manipulating prototypes ex vivo (in their hands), participants rated their willingness-to-try on a 100-point visual analog scale. The appropriateness of size and firmness were evaluated using 5-point just-about-right (JAR) scales. Each participant evaluated all five prototypes individually. Samples were presented in a counterbalanced monadic sequence using a Williams design. Mean willingness-to-try varied by shape, with Bullet and Long Oval receiving significantly higher scores. This was consistent with JAR data for size, as 70% and 65% of women indicated these shapes were 'just-about-right', respectively. In contrast, a minority of women endorsed the other 3 shapes as having a size that was 'just-about-right'. The proportion of women who felt the firmness was 'just-about-right' was uniformly high, irrespective of shape, suggesting prior attempts to optimize the formula were successful. Perceptions of size and firmness were influenced by the physical length and width of the prototypes, in spite of having constant volume. Women showed high willingness-to-try when asked to assume they were at risk. These results are relevant for behavioral and formulation scientists working on microbicides, to better understand the influence of sensory attributes on acceptability, as acceptability and compliance ultimately impact effectiveness.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276592      PMCID: PMC3608716          DOI: 10.1016/j.antiviral.2012.12.024

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  19 in total

Review 1.  Microbicides: a new approach to preventing HIV and other sexually transmitted infections.

Authors:  Alan Stone
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  A framework for examining the sustained acceptability of microbicides.

Authors:  Lawrence J Severy; Elizabeth Tolley; Cynthia Woodsong; Greg Guest
Journal:  AIDS Behav       Date:  2005-03

4.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

5.  Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.

Authors:  Annalene M Nel; Lynne B Mitchnick; Peter Risha; Lungwani Tyson Makoye Muungo; Pamela M Norick
Journal:  J Womens Health (Larchmt)       Date:  2011-07-20       Impact factor: 2.681

6.  Acceptability of Carraguard vaginal gel use among Thai couples.

Authors:  Sara J Whitehead; Peter H Kilmarx; Kelly Blanchard; Chomnad Manopaiboon; Supaporn Chaikummao; Barbara Friedland; Jullapong Achalapong; Mayuree Wankrairoj; Philip Mock; Sombat Thanprasertsuk; Jordan W Tappero
Journal:  AIDS       Date:  2006-11-14       Impact factor: 4.177

Review 7.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

8.  The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Authors:  Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2003-09       Impact factor: 2.681

9.  Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.

Authors:  Ana Ventuneac; Alex Carballo-Diéguez; Ian McGowan; Robert Dennis; Amy Adler; Elena Khanukhova; Charles Price; Terry Saunders; Chomchay Siboliban; Peter Anton
Journal:  AIDS Behav       Date:  2009-09-11

10.  Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa.

Authors:  Gita Ramjee; Neetha S Morar; Sarah Braunstein; Barbara Friedland; Heidi Jones; Janneke van de Wijgert
Journal:  AIDS Res Ther       Date:  2007-09-27       Impact factor: 2.250

View more
  10 in total

1.  Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Authors:  Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 2.  Designing and developing suppository formulations for anti-HIV drug delivery.

Authors:  Anthony S Ham; Robert W Buckheit
Journal:  Ther Deliv       Date:  2017-08

Review 3.  On-demand microbicide products: design matters.

Authors:  Sravan Kumar Patel; Lisa Cencia Rohan
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

4.  Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use.

Authors:  Kate M Guthrie; Rochelle K Rosen; Melissa Guillen; Jaime J Ramirez; Sara E Vargas; Joseph L Fava; Anthony S Ham; David F Katz; Susan Cu-Uvin; Sheila Tumilty; Kelley A Smith; Karen W Buckheit; Robert W Buckheit
Journal:  AIDS Res Hum Retroviruses       Date:  2021-10-18       Impact factor: 1.723

5.  Relationships between perceptual attributes and rheology in over-the-counter vaginal products: a potential tool for microbicide development.

Authors:  Ellen D Mahan; Toral Zaveri; Gregory R Ziegler; John E Hayes
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

6.  Design aspects of vaginal applicators that influence acceptance among target users.

Authors:  Alyssa J Bakke; Toral Zaveri; Molly J Higgins; Gregory R Ziegler; John E Hayes
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

7.  Release of tenofovir from carrageenan-based vaginal suppositories.

Authors:  Toral Zaveri; John E Hayes; Gregory R Ziegler
Journal:  Pharmaceutics       Date:  2014-07-04       Impact factor: 6.321

8.  Firmness Perception Influences Women's Preferences for Vaginal Suppositories.

Authors:  Toral Zaveri; Rachel J Primrose; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Pharmaceutics       Date:  2014-09-10       Impact factor: 6.321

9.  Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint Analysis.

Authors:  Rachel J Primrose; Toral Zaveri; Alyssa J Bakke; Gregory R Ziegler; Howard R Moskowitz; John E Hayes
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

10.  Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories.

Authors:  Toral Zaveri; Kimberly A Powell; Kate M Guthrie; Alyssa J Bakke; Gregory R Ziegler; John E Hayes
Journal:  BMC Womens Health       Date:  2018-10-20       Impact factor: 2.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.